Developing tiny metallic mesh tube devices to treat patients suffering from brain aneurysms.
Location: United Kingdom, England, Oxford
Total raised: $20.16M
Investors 4
| Date | Name | Website |
| - | Oxford Uni... | innovation... |
| - | Oxford Inv... | oxfordinve... |
| - | Parkwalk A... | parkwalkad... |
| - | Oxford Sci... | oxfordscie... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 21.05.2024 | Series A | $10.16M | - |
| 08.04.2021 | Series A | $10M | - |
Mentions in press and media 10
| Date | Title | Description |
| 30.12.2024 | Knowledge Intensive EIS Fund IV launch | We are pleased to announce the launch of the Parkwalk Knowledge Intensive EIS Fund IV, an HMRC-approved EIS Fund. The fourth Knowledge Intensive Fund will back cutting-edge technology companies spun out of leading UK universities and resea... |
| 21.05.2024 | Oxford Endovascular: Revolutionizing Brain Aneurysm Treatment | Oxford Endovascular, a spinout from Oxford University, has secured £8 million in funding to advance its groundbreaking brain aneurysm technology. The company's innovative device, OXIFLOW, aims to reduce the occurrence of brain hemorrhage by... |
| 21.05.2024 | Oxford Endovascular – raises £8m to tackle brain aneurysms | Delighted to announce our latest investment in Oxford Endovascular, a spin-out from Oxford University, working to prevent brain haemorrhage by treating brain aneurysms, a condition that affects 1 in 50 persons. The investment was featured i... |
| 20.05.2024 | Oxford Endovascular Closes GBP8M Series A+ Funding | Oxford Endovascular, an Oxford, UK-based medtech startup, closed an GBP8m in Series A+ funding round. The round was led by Parkwalk Advisors with participation from Norcliffe Capital, Oxford Science Enterprises (OSE), Vulpes and the Univers... |
| 20.05.2024 | Oxford Endovascular raises £8M for aneurysm treatment device | Oxford University spinout Oxford Endovascular has secured £8M in a Series A funding round to advance its brain aneurysm technology. The company hopes to perform human trials in the near future. The medtech startup, founded in 2015, hopes to... |
| 08.04.2021 | Oxford Endovascular raises $10M to develop ‘origami’ medical device | Credit: OxiFlow |
| 08.04.2021 | Oxford Endovascular Raises $10M in Funding | Oxford Endovascular, a British MedTech company, raised $10m in a series A funding round. Backers included a £3m investment from new investors Vulpes Investment Management, who joined to lead the round and funds from the Additio Investment G... |
| 09.07.2020 | EIT Health aids 11 start-ups disrupted by COVID-19 | EIT Health has awarded €5.5 million to start-ups in Europe to support with business continuity in response to the disruptions caused by the COVID-19 pandemic. The Start-up Rescue Instrument was initiated by EIT Health in May and called on h... |
| - | Oxford Endovascular – raises $10m Series A round | Parkwalk are pleased to announce an investment in Oxford Endovascular as part of a $10m Series A funding round, to develop an origami engineered medical device to prevent brain haemorrhage. |
| - | Oxford Endovascular | “oxfordendovascular” |